TipRanks
Compugen Ltd (DE:CW9)
BERLIN:CW9
Germany Market

Compugen (CW9) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CW9 Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Compugen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CW9 Stock 12 Month Forecast

Average Price Target

€4.01
▲(165.34% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Compugen in the last 3 months. The average price target is €4.01 with a high forecast of €5.34 and a low forecast of €3.56. The average price target represents a 165.34% change from the last price of €1.51.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","3":"€3","6":"€6","1.5":"€1.5","4.5":"€4.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5.3420991,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€5.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.006574325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€4.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5613994,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€3.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.5,3,4.5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.51,1.804776853846154,2.0995537076923076,2.3943305615384616,2.6891074153846155,2.9838842692307694,3.2786611230769234,3.573437976923077,3.8682148307692312,4.162991684615385,4.457768538461539,4.752545392307693,5.047322246153846,{"y":5.3420991,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.51,1.7020441788461538,1.8940883576923078,2.0861325365384618,2.2781767153846153,2.4702208942307693,2.662265073076923,2.854309251923077,3.046353430769231,3.238397609615385,3.430441788461539,3.622485967307693,3.814530146153846,{"y":4.006574325,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.51,1.6677999538461539,1.8255999076923077,1.9833998615384616,2.1411998153846152,2.298999769230769,2.456799723076923,2.614599676923077,2.7723996307692307,2.9301995846153845,3.0879995384615384,3.2457994923076923,3.403599446153846,{"y":3.5613994,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.51,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€5.34Average Price Target€4.01Lowest Price Target€3.56
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:CW9
H.C. Wainwright
H.C. Wainwright
€3.56
Buy
135.85%
Upside
Reiterated
10/12/26
H.C. Wainwright Sticks to Its Buy Rating for Compugen (CGEN)
Stifel Nicolaus Analyst forecast on DE:CW9
Stifel Nicolaus
Stifel Nicolaus
€3.56
Buy
135.85%
Upside
Reiterated
10/06/26
Stifel Nicolaus Remains a Buy on Compugen (CGEN)
Oppenheimer Analyst forecast on DE:CW9
Oppenheimer
Oppenheimer
€3.56
Buy
135.85%
Upside
Reiterated
10/06/26
Compugen (CGEN) Receives a Buy from Oppenheimer
Lake Street Analyst forecast on DE:CW9
Lake Street
Lake Street
€5.34
Buy
253.78%
Upside
Reiterated
10/06/26
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (NASDAQ: STOK) and Compugen (NASDAQ: CGEN)
Leerink Partners Analyst forecast on DE:CW9
Leerink Partners
Leerink Partners
€11.57→€4.45
Buy
194.82%
Upside
Reiterated
05/21/26
Compugen price target lowered to $5 from $13 at LeerinkCompugen price target lowered to $5 from $13 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:CW9
H.C. Wainwright
H.C. Wainwright
€3.56
Buy
135.85%
Upside
Reiterated
10/12/26
H.C. Wainwright Sticks to Its Buy Rating for Compugen (CGEN)
Stifel Nicolaus Analyst forecast on DE:CW9
Stifel Nicolaus
Stifel Nicolaus
€3.56
Buy
135.85%
Upside
Reiterated
10/06/26
Stifel Nicolaus Remains a Buy on Compugen (CGEN)
Oppenheimer Analyst forecast on DE:CW9
Oppenheimer
Oppenheimer
€3.56
Buy
135.85%
Upside
Reiterated
10/06/26
Compugen (CGEN) Receives a Buy from Oppenheimer
Lake Street Analyst forecast on DE:CW9
Lake Street
Lake Street
€5.34
Buy
253.78%
Upside
Reiterated
10/06/26
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (NASDAQ: STOK) and Compugen (NASDAQ: CGEN)
Leerink Partners Analyst forecast on DE:CW9
Leerink Partners
Leerink Partners
€11.57→€4.45
Buy
194.82%
Upside
Reiterated
05/21/26
Compugen price target lowered to $5 from $13 at LeerinkCompugen price target lowered to $5 from $13 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Compugen

3 Months
Stephen WilleyStifel Nicolaus
Success Rate
5/11 ratings generated profit
45%
Average Return
+2.87%
Copying Stephen Willey's trades and holding each position for 3 Months would result in 45.45% of your transactions generating a profit, with an average return of +2.87% per trade.
1 Year
Daina GrayboschLeerink Partners
Success Rate
6/27 ratings generated profit
22%
Average Return
-11.91%
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -11.91% per trade.
2 Years
Stephen WilleyStifel Nicolaus
Success Rate
6/11 ratings generated profit
55%
Average Return
+5.25%
Copying Stephen Willey's trades and holding each position for 2 Years would result in 54.55% of your transactions generating a profit, with an average return of +5.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CW9 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
5
5
5
4
8
Buy
1
1
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
5
4
8
In the current month, CW9 has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CW9 average Analyst price target in the past 3 months is 4.01.
Each month's total comprises the sum of three months' worth of ratings.

CW9 Financial Forecast

CW9 Earnings Forecast

Next quarter’s earnings estimate for CW9 is -€0.07 with a range of -€0.09 to -€0.05. The previous quarter’s EPS was -€0.06. CW9 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CW9 has Performed in-line its overall industry.
Next quarter’s earnings estimate for CW9 is -€0.07 with a range of -€0.09 to -€0.05. The previous quarter’s EPS was -€0.06. CW9 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CW9 has Performed in-line its overall industry.

CW9 Sales Forecast

Next quarter’s sales forecast for CW9 is €1.14M with a range of €0.00 to €2.25M. The previous quarter’s sales results were €2.32M. CW9 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CW9 has Performed in-line its overall industry.
Next quarter’s sales forecast for CW9 is €1.14M with a range of €0.00 to €2.25M. The previous quarter’s sales results were €2.32M. CW9 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CW9 has Performed in-line its overall industry.

CW9 Stock Forecast FAQ

What is DE:CW9’s average 12-month price target, according to analysts?
Based on analyst ratings, Compugen Ltd’s 12-month average price target is 4.01.
    What is DE:CW9’s upside potential, based on the analysts’ average price target?
    Compugen Ltd has 165.34% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Compugen Ltd a Buy, Sell or Hold?
          Compugen Ltd has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Compugen Ltd’s share price target?
            The average share price target for Compugen Ltd is 4.01. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €5.34 ,and the lowest forecast is €3.56. The average share price target represents 165.34% Increase from the current price of €1.51.
              What do analysts say about Compugen Ltd?
              Compugen Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Compugen Ltd?
                To buy shares of DE:CW9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.